Contents

Current Radiopharmaceuticals, Volume 1 - Number 3

Editorial [Hot topic:Targeted Alpha Particle Therapy (Guest Editors: Ganesan Vaidyanathan and Roy Larsen)]

, 1(3): 125 - 126

GANESAN VAIDYANATHAN and ROY H. LARSEN


DOI: 10.2174/1874471010801030125




Commercial Availability of Alpha-Emitting Radionuclides for Medicine

, 1(3): 127 - 134

Darrell R. Fisher


DOI: 10.2174/1874471010801030127




Production of Alpha Emitters for Targeted Alpha Therapy

, 1(3): 135 - 143

A. Morgenstern, K. Abbas, F. Bruchertseifer and C. Apostolidis


DOI: 10.2174/1874471010801030135




[211At]Astatine-Labeled Compound Stability: Issues with Released [211At]Astatide and Development of Labeling Reagents to Increase Stability

, 1(3): 144 - 176

D. Scott Wilbur


DOI: 10.2174/1874471010801030144




Astatine Radiopharmaceuticals: Prospects and Problems

, 1(3): 177 - 196

Ganesan Vaidyanathan and Michael R. Zalutsky


DOI: 10.2174/1874471010801030177




Experimental Targeted Therapy Using [211At]meta-Astatobenzylguanidine and Transfection of the Noradrenaline Transporter Gene

, 1(3): 197 - 202

M. Boyd, A. G. McCluskey, A. Sorensen and R. J. Mairs


DOI: 10.2174/1874471010801030197




Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy

, 1(3): 203 - 208

Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen


DOI: 10.2174/1874471010801030203




Targeted Alpha-Particle Therapy with 227Th-Labeled Antibodies

, 1(3): 209 - 214

Jostein Dahle and Roy H. Larsen


DOI: 10.2174/1874471010801030209




Treatment of Diffuse-Type Gastric Cancer Cells Using 213Bi-Radioimmunoconjugates In Vitro and In Vivo Following Intraperitoneal Dissemination

, 1(3): 215 - 224

Christof Seidl and Reingard Senekowitsch-Schmidtke


DOI: 10.2174/1874471010801030215




Targeting EGFR and HER2 with 211At-Labeled Molecules: Unexpected and Expected Dose-Effect Relations in Cultured Tumor Cells

, 1(3): 225 - 233

J. Carlsson, A. C. Steffen, A. L. Sundberg, M. Vikstrom, A. Orlova, L. Gedda, B. Stenerlow, H. Lundqvist and V. Tolmachev


DOI: 10.2174/1874471010801030225




Radioimmunotherapy of Infection with 213Bi-Labeled Antibodies

, 1(3): 234 - 239

Ekaterina Dadachova


DOI: 10.2174/1874471010801030234




New Directions for Clinical Trials of Targeted Alpha Therapy for Metastatic Melanoma

, 1(3): 240 - 250

Barry J. Allen, Chand Raja, Syed M.A. Rizvi, Peter Graham and John H. Kearsley


DOI: 10.2174/1874471010801030240




Targeted α-Particle Therapy: A Clinical Overview

, 1(3): 251 - 253

Massimo Salvatori, Luca Indovina and Luigi Mansi


DOI: 10.2174/1874471010801030251




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science